Lung inflammatory diseases such as ALI/ARDS, asthma, idiopathic pulmonary fibrosis (IPF), bronchoalveolar dysplasia (BPD), and chronic obstructive pulmonary disease (COPD) are also characterized by dysregulated NF-κB activation (Figure 4) [33,34,35,36,37,38]. This evidence concerns the gene NFKB1 and chronic obstructive pulmonary disease.